.Atea Pharmaceuticals' antiviral has neglected one more COVID-19 test, but the biotech still holds o...
.Neurocrine Biosciences' schizophrenia plan pivot has actually failed. The biotech was not able to d...
.Sanofi has brought in a late entrance to the radioligand party, paying 100 million europeans ($ 110...
.After F2G's very first attempt to acquire a brand-new lesson of antifungal to market was thwarted d...
.Moderna has pledged to cut R&D costs by $1.1 billion through 2027. The choice to shrink the budg...
.Just 4 months after Sanofi bet $80 million in upfront money on Pivot Therapeutics' losmapimod, the ...
.Cancer provider Oncternal Therapies is actually folding all its own professional tests and laying o...
.Roche is holding out chances that its injectable weight problems possibility might inevitably displ...
.Novo Nordisk has actually elevated the cover on a stage 1 test of its dental amylin as well as GLP-...
.Merely a few quick full weeks after winning an FDA Fast lane tag for its own investigational BTK de...